DEA Classification Change for Tramadol

Tramadol (brand name Ultram) is a centrally-acting “opioid-like” analgesic. It was approved by the FDA in 1995.  Since then, generic, combination, and extended release formulations have also been approved.   Per the PMSI 2013 Annual Drug Trends Report for Workers’ Compensation, tramadol (brand name Ultram and Ultram ER) was ranked number 3 under the top 20 medications … Read moreDEA Classification Change for Tramadol

Physician Dispensing and Workers’ Compensation

Physician dispensing of repackaged drugs continues to be a major contributor to the growing cost of prescription drug treatment within the workers’ compensation industry. In the 2012 Survey of Prescription Drug Management released by CompPharma and authored by Joseph Paduda in January of 2013, it was noted that physician dispensed medications were second only to … Read morePhysician Dispensing and Workers’ Compensation

Keeping you Informed: Updates from the FDA on Opana ER and Ambien

There have been two recent drug announcements by the FDA affecting Opana ER and Ambien, both of which are commonly prescribed in workers’ compensation claims. On May 10, 2013, the FDA announced that generic versions of non-crush resistant Opana ER (indicated for treatment of moderate to severe pain in patients requiring around-the clock analgesia) could … Read moreKeeping you Informed: Updates from the FDA on Opana ER and Ambien

Update on Inclusion of Benzodiazepines and Barbiturates in WCMSAs

As of January 1, 2013, Medicare expanded its Part D guidelines to include coverage for benzodiazepines and barbiturates for certain conditions. For more information on this new expanded coverage, when it will be covered, and how this coverage change is predicted to apply to WCMSAs, please see our prior blog here. CMS recently issued an alert on their website … Read moreUpdate on Inclusion of Benzodiazepines and Barbiturates in WCMSAs